Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on October 28, 2014, reporting its financial results for the third quarter ended September 30, 2014. The key takeaway for investors is the release of these quarterly earnings, which are detailed in an accompanying press release filed as Exhibit 99.1. The company provided both GAAP and non-GAAP financial information, with management highlighting the utility of non-GAAP measures for internal operational and financial planning, and encouraging investors to consider them alongside GAAP results. The press release, not fully detailed in the 8-K itself but referenced as the primary source of financial data, would contain the specific revenue, earnings, and other key financial metrics for the quarter. Investors should refer to Exhibit 99.1 for detailed performance figures, including a reconciliation of GAAP to non-GAAP measures, to fully assess the company's operational performance and financial condition during the period.
Key Highlights
- 1Gilead Sciences announced its financial results for the third quarter ended September 30, 2014, via an 8-K filing on October 28, 2014.
- 2The detailed financial results are provided in a press release (Exhibit 99.1) accompanying the 8-K.
- 3Gilead presented financial information on both a U.S. GAAP and a non-GAAP basis.
- 4Management believes non-GAAP financial information is useful for investors and internal operational analysis.
- 5Investors are advised to use non-GAAP information as a supplement to, not a replacement for, GAAP financial statements.
- 6A reconciliation between GAAP and non-GAAP financial information is available in the referenced press release.
- 7The information provided in this 8-K and its exhibit is not deemed 'filed' for purposes of Section 18 of the Exchange Act.